6-Chloro-N-methylbenzo[d]thiazol-2-amine

Catalog No.: 
ACDTZX144
CAS No.: 
34551-19-4
Molecular Formula: 
C8H7ClN2S
Molecular Weight: 
198.68
6-Chloro-N-methylbenzo[d]thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$242.00InquiryInquiry
100mg97%$349.00InquiryInquiry
250mg97%$490.00InquiryInquiry
1g97%$974.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-N-methylbenzo[d]thiazol-2-amine
IUPAC Name6-chloro-N-methylbenzo[d]thiazol-2-amine
MDL No.MFCD08706215
Molecular FormulaC8H7ClN2S
Molecular Weight198.68
SMILESCNC1=NC2=CC=C(Cl)C=C2S1
InChI KeyLZCBQCKLQRWOJK-UHFFFAOYSA-N
Synonym2-Benzothiazolamine,6-chloro-N-methyl-(9CI);6-Chloro-N-Methyl-2-benzothiazolaMine;(6-CHLORO-BENZOTHIAZOL-2-YL)-METHYL-AMINE;6-chloro-N-methylbenzo[d]thiazol-2-amine;6-chloro-N-methyl-1,3-benzothiazol-2-amine;2-Benzothiazolamine, 6-chloro-N-methyl-
CAS No.34551-19-4

Synthetic Route by SureRoute

1. ACDTZX144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGFYE319 route compound structure diagram
    ACGFYE3193622-23-9In Stock
  4. Then
  5. ACDTZX144 route product structure diagram
    ACDTZX14434551-19-4
Inquiry

2. ACDTZX144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOMIL046 route compound structure diagram
    ACOMIL0463507-17-3In Stock
  4. Then
  5. ACDTZX144 route product structure diagram
    ACDTZX14434551-19-4
Inquiry

3. ACDTZX144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDTZX144 route product structure diagram
    ACDTZX14434551-19-4
Inquiry

Comments (0)